{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:53:31Z","timestamp":1772196811984,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T00:00:00Z","timestamp":1632528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronavirus SARS-CoV-2 causes COVID-19 illness which can progress to severe pneumonia. Empiric antibacterials are often employed though frequency of bacterial coinfection superinfection is debated and concerns raised about selection of bacterial antimicrobial resistance. We evaluated sputum bacterial and fungal growth from 165 intubated COVID-19 pneumonia patients. Objectives were to determine frequency of culture positivity, risk factors for and outcomes of positive cultures, and timing of antimicrobial resistance development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective reviews were conducted of COVID-19 pneumonia patients requiring intubation admitted to a 1058-bed four community hospital system on the east coast United States, March 1 to May 1, 2020. Length of stay (LOS) was expressed as mean (standard deviation); 95% confidence interval (95% CI) was computed for overall mortality rate using the exact binomial method, and overall mortality was compared across each level of a potential risk factor using a Chi-Square Test of Independence. All tests were two-sided, and significance level was set to 0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Average patient age was 68.7\u00a0years and LOS 19.9\u00a0days. Eighty-three patients (50.3% of total) originated from home, 10 from group homes (6.1% of total), and 72 from nursing facilities (43.6% of total). Mortality was 62.4%, highest for nursing home residents (80.6%). Findings from 253 sputum cultures overall did not suggest acute bacterial or fungal infection in 73 (45%) of 165 individuals sampled within 24\u00a0h of intubation. Cultures\u2009\u2265\u20091 week following intubation did grow potential pathogens in 72 (64.9%) of 111 cases with 70.8% consistent with late pneumonia and 29.2% suggesting colonization. Twelve (10.8% of total) of these late post-intubation cultures revealed worsened antimicrobial resistance predominantly in\n                      <jats:italic>Pseudomonas<\/jats:italic>\n                      ,\n                      <jats:italic>Enterobacter, or Staphylococcus aureus<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In severe COVID-19 pneumonia, a radiographic ground glass interstitial pattern and lack of purulent sputum prior to\/around the time of intubation correlated with no culture growth or recovery of normal oral flora\u2009\u00b1\u2009yeast. Discontinuation of empiric antibacterials should be considered in these patients aided by other clinical findings, history of prior antimicrobials, laboratory testing, and overall clinical course. Continuing longterm hospitalisation and antibiotics are associated with sputum cultures reflective of hospital-acquired microbes and increasing antimicrobial resistance.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : Not applicable as this was a retrospective chart review study without interventional arm.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-021-00472-5","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T11:02:41Z","timestamp":1632567761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors"],"prefix":"10.1186","volume":"20","author":[{"given":"Hans H.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Yaron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Stahl","family":"Piraino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Kapelusznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"472_CR1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3566166","author":"A Kumar","year":"2020","unstructured":"Kumar A, Arora A, Sharma P, et al. Clinical Features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. SSRN [Preprint]. 2020. https:\/\/doi.org\/10.2139\/ssrn.3566166.","journal-title":"SSRN [Preprint]."},{"issue":"8","key":"472_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","volume":"38","author":"RL Chua","year":"2020","unstructured":"Chua RL, Lukassen S, Trump S, et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38(8):970\u20139. https:\/\/doi.org\/10.1038\/s41587-020-0602-4 (Epub 2020 Jun 26 PMID: 32591762).","journal-title":"Nat Biotechnol"},{"key":"472_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250\u20136. https:\/\/doi.org\/10.1002\/jmv.26232.","journal-title":"J Med Virol"},{"key":"472_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"472_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5.","journal-title":"Lancet"},{"issue":"10247","key":"472_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","volume":"396","author":"BT Bradley","year":"2020","unstructured":"Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. The Lancet. 2020;396(10247):320. https:\/\/doi.org\/10.1016\/S0140-6736(20)31305-2.","journal-title":"The Lancet"},{"issue":"18","key":"472_CR7","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.1007\/s00253-020-10814-6","volume":"104","author":"X Chen","year":"2020","unstructured":"Chen X, Liao B, Cheng L, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104(18):7777\u201385. https:\/\/doi.org\/10.1007\/s00253-020-10814-6.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"472_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmi.2020.09.025","volume":"27","author":"TM Rawson","year":"2021","unstructured":"Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27(1):9\u201311. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.025.","journal-title":"Clin Microbiol Infect"},{"key":"472_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/s12879-018-3548-0","volume":"18","author":"CR MacIntyre","year":"2018","unstructured":"MacIntyre CR, Chughtai AA, Barnes M, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N). BMC Infect Dis. 2018;18:637. https:\/\/doi.org\/10.1186\/s12879-018-3548-0.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"472_CR10","doi-asserted-by":"publisher","first-page":"ofaa066","DOI":"10.1093\/ofid\/ofaa066","volume":"7","author":"G Abelenda-Alonso","year":"2020","unstructured":"Abelenda-Alonso G, Rombauts A, Gudiol C, et al. Influenza and bacterial coinfection in adults with community-acquired pneumonia admitted to conventional wards: risk factors, clinical features, and outcomes. Open Forum Infect Dis. 2020;7(3):ofaa066. https:\/\/doi.org\/10.1093\/ofid\/ofaa066.","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"472_CR11","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s10096-020-03923-7","volume":"39","author":"F Waldeck","year":"2020","unstructured":"Waldeck F, Boroli F, Suh N, et al. Influenza-associated aspergillosis in critically-ill patients\u2014a retrospective bicentric cohort study. Eur J Clin Microbiol Infect Dis. 2020;39(10):1915\u201323. https:\/\/doi.org\/10.1007\/s10096-020-03923-7 (Epub 2020 Jun 3. PMID: 32494955; PMCID: PMC7266735).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"472_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1086\/422641","volume":"39","author":"FH Yap","year":"2004","unstructured":"Yap FH, Gomersall CD, Fung KS, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis. 2004;39(4):511\u20136. https:\/\/doi.org\/10.1086\/422641.","journal-title":"Clin Infect Dis"},{"key":"472_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijid.2014.06.003","volume":"25","author":"ZA Memish","year":"2014","unstructured":"Memish ZA, Almasri M, Turkestani A, Al-Shangiti AM, Yezli S. Etiology of severe community-acquired pneumonia during the 2013 Hajj-part of the MERS-CoV surveillance program. Int J Infect Dis. 2014;25:186\u201390. https:\/\/doi.org\/10.1016\/j.ijid.2014.06.003.","journal-title":"Int J Infect Dis"},{"key":"472_CR14","unstructured":"World Health Organization. COVID-19 Clinical Management. Living Guidance 25 January 2021. Available from: https:\/\/www.who\/int\/iris\/handle\/10665\/338882. Accessed 6 Mar 2021."},{"key":"472_CR15","doi-asserted-by":"publisher","unstructured":"Rawson TM, Moore LSP, Zhu N et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing [Preprint].\u00a0Clin Infect Dis. 2020;530. https:\/\/doi.org\/10.1093\/cid\/ciaa530.","DOI":"10.1093\/cid\/ciaa530"},{"issue":"2","key":"472_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/23744235.2020.1839672","volume":"53","author":"Z Karami","year":"2021","unstructured":"Karami Z, Knoop BT, Dofferhoff ASM, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis (Lond). 2021;53(2):102\u201310. https:\/\/doi.org\/10.1080\/23744235.2020.1839672.","journal-title":"Infect Dis (Lond)"},{"issue":"2","key":"472_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/antibiotics10020132","volume":"10","author":"S Grau","year":"2021","unstructured":"Grau S, Echeverria-Esnal D, G\u00f3mez-Zorrilla S, et al. Evolution of antimicrobial consumption during the first wave of COVID-19 pandemic. Antibiotics. 2021;10(2):132. https:\/\/doi.org\/10.3390\/antibiotics10020132.","journal-title":"Antibiotics"},{"key":"472_CR18","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","volume":"72","author":"VM Vaughn","year":"2020","unstructured":"Vaughn VM, Gandhi T, Petty LA, et al. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital cohort study. Clin Infect Dis. 2020;72:e533. https:\/\/doi.org\/10.1093\/cid\/ciaa1239 (published online ahead of print, 2020 Aug 21).","journal-title":"Clin Infect Dis"},{"key":"472_CR19","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1093\/cid\/ciaa954","volume":"73","author":"EC Somers","year":"2020","unstructured":"Somers EC, Eschenauer GA, Troost JP, et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clin Infect Dis. 2020;73:e445. https:\/\/doi.org\/10.1093\/cid\/ciaa954.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"472_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436 (Epub 2020 Jul 17. PMID: 32678530; PMCID: PMC7383595).","journal-title":"N Engl J Med"},{"key":"472_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.15.20103531","author":"LM Dimmig","year":"2020","unstructured":"Dimmig LM, Wu D, Gold M, et al. IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.15.20103531.","journal-title":"medRxiv"},{"key":"472_CR22","doi-asserted-by":"publisher","unstructured":"Antimicrobial resistance in the age of COVID-19 [Editorial].\u00a0Nat Microbiol. 5:779 (2020). https:\/\/doi.org\/10.1038\/s41564-020-0739-4.","DOI":"10.1038\/s41564-020-0739-4"},{"key":"472_CR23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2471\/BLT.20.268573","volume":"98","author":"H Getahun","year":"2020","unstructured":"Getahun H, Smith I, Trivedi K, et al. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98:442-442A.","journal-title":"Bull World Health Organ"},{"key":"472_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.02.013","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2021","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Rossolini GM, Schultsz C, et al. AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J Global Antimicrob Resist. 2021. https:\/\/doi.org\/10.1016\/j.jgar.2021.02.013.","journal-title":"J Global Antimicrob Resist"},{"key":"472_CR25","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ajic.2020.06.192","volume":"48","author":"L Rossato","year":"2020","unstructured":"Rossato L, Negr\u00e3o FJ, Simionatto S. Could the COVID-19 pandemic aggravate antimicrobial resistance? Am J Infect Control. 2020;48:1129\u201330. https:\/\/doi.org\/10.1016\/j.ajic.2020.06.192 (Epub 2020 Jun 27. PMID: 32603851; PMCID: PMC7320258).","journal-title":"Am J Infect Control"},{"key":"472_CR26","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/S2666-5247(20)30036-7","volume":"1","author":"H Adler","year":"2020","unstructured":"Adler H, Ball R, Fisher M, et al. Low rate of bacterial co-infection in patients with COVID-19. The Lancet Microbe. 2020;1:e62.","journal-title":"The Lancet Microbe"},{"issue":"3","key":"472_CR27","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.jinf.2020.06.056","volume":"81","author":"J Youngs","year":"2020","unstructured":"Youngs J, Wyncoll D, Hopkins P, et al. Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza. J Infect. 2020;81(3):e55\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2020.06.056.","journal-title":"J Infect"},{"key":"472_CR28","doi-asserted-by":"publisher","first-page":"198005","DOI":"10.1016\/j.virusres.2020.198005","volume":"285","author":"X Zhu","year":"2020","unstructured":"Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005. https:\/\/doi.org\/10.1016\/j.virusres.2020.198005.","journal-title":"Virus Res"},{"key":"472_CR29","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cmi.2020.04.024","volume":"26","author":"BD Huttner","year":"2020","unstructured":"Huttner BD, Catho G, Pano-Pardo JR, et al. COVID-19: don\u2019t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020;26:808\u201310. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.024.","journal-title":"Clin Microbiol Infect"},{"key":"472_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s13054-020-03135-7","volume":"24","author":"A Verroken","year":"2020","unstructured":"Verroken A, Scohy A, Gerard L, et al. Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis. Crit Care. 2020;24:410. https:\/\/doi.org\/10.1186\/s13054-020-03135-7.","journal-title":"Crit Care"},{"issue":"10","key":"472_CR31","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","volume":"26","author":"S Hughes","year":"2020","unstructured":"Hughes S, Troise O, Donaldson H, et al. Bacterial and fungal coinfection among hospitalised patients with COVID-19: a retrospective cohort study in a UK secondary care setting. Clin Microbiol Infect. 2020;26(10):1395\u20139. https:\/\/doi.org\/10.1016\/j.cmi.2020.06.025 (Epub 2020 Jun 27. PMID: 32603803; PMCID: PMC7320692).","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"472_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal C, Sanjuan G, Moreno-Garc\u00eda E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.041 (Epub 2020 Jul 31).","journal-title":"Clin Microbiol Infect"},{"key":"472_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13613-020-00736-x","volume":"10","author":"D Contou","year":"2020","unstructured":"Contou D, Claudinon A, Pajot O, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10:119. https:\/\/doi.org\/10.1186\/s13613-020-00736-x.","journal-title":"Ann Intensive Care"},{"key":"472_CR34","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/jmv.26441","volume":"93","author":"AGM Neto","year":"2021","unstructured":"Neto AGM, Lo KB, Wattoo A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol. 2021;93:1489\u201395. https:\/\/doi.org\/10.1002\/jmv.26441.","journal-title":"J Med Virol"},{"issue":"1","key":"472_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/ice.2020.368","volume":"42","author":"P Nori","year":"2021","unstructured":"Nori P, Cowman K, Chen V, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2021;42(1):84\u20138. https:\/\/doi.org\/10.1017\/ice.2020.368.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"472_CR36","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1093\/cid\/ciaa524.PMID:32361747;PMCID:PMC7197597","volume":"71","author":"CJ Clancy","year":"2020","unstructured":"Clancy CJ, Nguyen MH. Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect? Clin Infect Dis. 2020;71(10):2736\u201343. https:\/\/doi.org\/10.1093\/cid\/ciaa524.PMID:32361747;PMCID:PMC7197597.","journal-title":"Clin Infect Dis"},{"key":"472_CR37","doi-asserted-by":"publisher","unstructured":"M. Vaillancourt, Jorth P. The unrecognized threat of secondary bacterial infections with COVID-19. mBio. 2020;11. https:\/\/doi.org\/10.1128\/mBio.01806-20.","DOI":"10.1128\/mBio.01806-20"},{"issue":"5","key":"472_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciaa762","volume":"72","author":"E Dudoignon","year":"2021","unstructured":"Dudoignon E, Cam\u00e9l\u00e9na F, Deniau B, et al. Bacterial pneumonia in COVID-19 critically ill patients: a case series. Clin Infect Dis. 2021;72(5):905\u20136. https:\/\/doi.org\/10.1093\/cid\/ciaa762.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"472_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30036-7","volume":"1","author":"H Adler","year":"2020","unstructured":"Adler H, Ball R, Fisher M, et al. Low rate of bacterial co-infection in patients with COVID-19. Lancet Microbe. 2020;1(2): e62. https:\/\/doi.org\/10.1016\/S2666-5247(20)30036-7.","journal-title":"Lancet Microbe"},{"key":"472_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.inf2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19; a systemic review and meta-analysis. J Infection. 2020;81:266\u201375. https:\/\/doi.org\/10.1016\/j.inf2020.05.046.","journal-title":"J Infection"},{"key":"472_CR41","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm87a.ccc015","author":"C-P Wu","year":"2020","unstructured":"Wu C-P, Adhi F, Highland K. Recognition and management of respiratory coinfection and secondary pneumonia in patients with COVID-19. Cleveland Clin J Med. 2020. https:\/\/doi.org\/10.3949\/ccjm87a.ccc015.","journal-title":"Cleveland Clin J Med"},{"issue":"4","key":"472_CR42","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/jac\/dkaa530","volume":"76","author":"M Falcone","year":"2021","unstructured":"Falcone M, Tiseo G, Giordano C, et al. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021;76(4):1078\u201384. https:\/\/doi.org\/10.1093\/jac\/dkaa530.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"472_CR43","doi-asserted-by":"publisher","first-page":"e02136","DOI":"10.1128\/JCM.02136-20","volume":"59","author":"AM Borman","year":"2020","unstructured":"Borman AM, Palmer MD, Fraser M, et al. COVID-19-associated invasive aspergillosis: data from the UK National Mycology Reference Laboratory. J Clin Microbiol. 2020;59(1):e02136. https:\/\/doi.org\/10.1128\/JCM.02136-20.","journal-title":"J Clin Microbiol"},{"key":"472_CR44","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1038\/s41598-021-83642-x","volume":"11","author":"KW Kim","year":"2021","unstructured":"Kim KW, Deveson IW, Pang CNI, et al. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Sci Rep. 2021;11:3934. https:\/\/doi.org\/10.1038\/s41598-021-83642-x.","journal-title":"Sci Rep"},{"key":"472_CR45","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1017\/ice.2020.156","volume":"41","author":"P Zhou","year":"2020","unstructured":"Zhou P, Liu Z, Chen Y, et al. Bacterial and fungal infections in COVID-19 patients: a matter of concern [letter to the editor]. Infect Control Hosp Epidemiol. 2020;41:1124. https:\/\/doi.org\/10.1017\/ice.2020.156.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"472_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.06.033","author":"B Cheng","year":"2020","unstructured":"Cheng B, Hu J, Zuo X, et al. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. Clin Micro Infect. 2020. https:\/\/doi.org\/10.1016\/j.cmi.2020.06.033.","journal-title":"Clin Micro Infect"},{"issue":"7","key":"472_CR47","doi-asserted-by":"publisher","first-page":"e12560","DOI":"10.15252\/emmm.202012560","volume":"12","author":"JA Bengoechea","year":"2020","unstructured":"Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7):e12560. https:\/\/doi.org\/10.15252\/emmm.202012560 (Epub 2020 Jun 15. PMID: 32453917; PMCID: PMC7283846).","journal-title":"EMBO Mol Med"},{"key":"472_CR48","doi-asserted-by":"publisher","unstructured":"Townsend L, Hughes G, Kerr C, et al. Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC-Antimicrob Resist. 2020;2. https:\/\/doi.org\/10.1093\/jacamr\/dlaa071.","DOI":"10.1093\/jacamr\/dlaa071"},{"issue":"4","key":"472_CR49","doi-asserted-by":"publisher","first-page":"e01806","DOI":"10.1128\/mBio.01806-20","volume":"11","author":"M Vaillancourt","year":"2020","unstructured":"Vaillancourt M, Jorth P. The unrecognized threat of secondary bacterial infections with COVID-19. MBio. 2020;11(4):e01806. https:\/\/doi.org\/10.1128\/mBio.01806-20.","journal-title":"MBio"},{"key":"472_CR50","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/jac\/dkaa194","volume":"75","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Castro-Sanchez E, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75:1681\u20134. https:\/\/doi.org\/10.1093\/jac\/dkaa194.","journal-title":"J Antimicrob Chemother"},{"key":"472_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa049","author":"CJ Clancy","year":"2020","unstructured":"Clancy CJ, Buehrle DJ, Nguyen MH. PRO: the COVID-19 pandemic will result in increased antimicrobial resistance rates. JAC Antimicrob Resist. 2020. https:\/\/doi.org\/10.1093\/jacamr\/dlaa049.","journal-title":"JAC Antimicrob Resist."},{"key":"472_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaa051","author":"P Callignon","year":"2020","unstructured":"Callignon P, Beggs JJ. CON: COVID-19 will not result in increased antimicrobial resistance prevalence. JAC Antimicrob Resist. 2020. https:\/\/doi.org\/10.1093\/jacamr\/dlaa051.","journal-title":"JAC Antimicrob Resist."},{"key":"472_CR53","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/iub.2356","volume":"72","author":"R Mirzaei","year":"2020","unstructured":"Mirzaei R, Goodarzi P, Asadi M, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020;72:2097\u2013111. https:\/\/doi.org\/10.1002\/iub.2356.","journal-title":"IUBMB Life"},{"issue":"9","key":"472_CR54","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.ajic.2020.06.185","volume":"48","author":"J Intra","year":"2020","unstructured":"Intra J, Sarto C, Beck E, et al. Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected. Am J of Infect. 2020;48(9):1130\u20131. https:\/\/doi.org\/10.1016\/j.ajic.2020.06.185.","journal-title":"Am J of Infect"},{"key":"472_CR55","doi-asserted-by":"publisher","unstructured":"Pickens CO, Gao CA, Cuttica MJ et al. Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. Am J Resp Crit Care Med. https:\/\/doi.org\/10.1164\/rccm.202106-1354OC.","DOI":"10.1164\/rccm.202106-1354OC"},{"issue":"7","key":"472_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254671.PMID:34255801;PMCID:PMC8277025","volume":"16","author":"JC Cata\u00f1o-Correa","year":"2021","unstructured":"Cata\u00f1o-Correa JC, Cardona-Arias JA, Porras Mancilla JP, et al. Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medell\u00edn-Colombia, 2020. PLoS ONE. 2021;16(7): e0254671. https:\/\/doi.org\/10.1371\/journal.pone.0254671.PMID:34255801;PMCID:PMC8277025.","journal-title":"PLoS ONE"},{"issue":"3","key":"472_CR57","doi-asserted-by":"publisher","first-page":"065","DOI":"10.1093\/ofid\/ofab065","volume":"8","author":"CJ Clancy","year":"2021","unstructured":"Clancy CJ, Schwartz IS, Kula B, et al. Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies. Open Forum Infect Dis. 2021;8(3):065. https:\/\/doi.org\/10.1093\/ofid\/ofab065 (PMID: 33732753; PMCID: PMC7928570).","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"472_CR58","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chest.2021.04.002","volume":"160","author":"G Grasselli","year":"2021","unstructured":"Grasselli G, Scaravilli V, Mangioni D, et al. Hospital-acquired infections in critically ill patients with COVID-19. Chest. 2021;160(2):454\u201365.","journal-title":"Chest"},{"key":"472_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.08.003","author":"TE Meawed","year":"2021","unstructured":"Meawed TE, Ahmed SM, Mowafy SMS, et al. Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. J Infect Public Health. 2021. https:\/\/doi.org\/10.1016\/j.jiph.2021.08.003 (Epub ahead of print. PMID: 34420902; PMCID: PMC8349397).","journal-title":"J Infect Public Health"},{"issue":"3","key":"472_CR60","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jinf.2021.07.014","volume":"83","author":"C Gudiol","year":"2021","unstructured":"Gudiol C, Dur\u00e0-Miralles X, Aguilar-Company J, et al. Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study. J Infect. 2021;83(3):306\u201313. https:\/\/doi.org\/10.1016\/j.jinf.2021.07.014 (Epub ahead of print. PMID: 34302864; PMCID: PMC8295054).","journal-title":"J Infect"},{"issue":"1","key":"472_CR61","doi-asserted-by":"publisher","first-page":"10103","DOI":"10.1038\/s41598-021-89516-6.PMID:33980943;PMCID:PMC8115177","volume":"11","author":"P Gaibani","year":"2021","unstructured":"Gaibani P, Viciani E, Bartoletti M, et al. The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep. 2021;11(1):10103. https:\/\/doi.org\/10.1038\/s41598-021-89516-6.PMID:33980943;PMCID:PMC8115177.","journal-title":"Sci Rep"},{"key":"472_CR62","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jgar.2020.11.004","volume":"23","author":"G Montrucchio","year":"2020","unstructured":"Montrucchio G, Corcione S, Sales G, et al. Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball. J Glob Antimicrob Resist. 2020;23:398\u2013400. https:\/\/doi.org\/10.1016\/j.jgar.2020.11.004 (Epub 2020 Nov 23. PMID: 33242674; PMCID: PMC7682477).","journal-title":"J Glob Antimicrob Resist."},{"issue":"4","key":"472_CR63","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3201\/eid2704.204036","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel A, Emerick M, Cabunoc MK, et al. Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units. Emerg Infect Dis. 2021;27(4):1234\u20137. https:\/\/doi.org\/10.3201\/eid2704.204036 (Epub 2021 Feb 10. PMID: 33565961; PMCID: PMC8007317).","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"472_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC.PMID:33480831;PMCID:PMC7874326","volume":"203","author":"A Fekkar","year":"2021","unstructured":"Fekkar A, Lampros A, Mayaux J, et al. Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am J Respir Crit Care Med. 2021;203(3):307\u201317. https:\/\/doi.org\/10.1164\/rccm.202009-3400OC.PMID:33480831;PMCID:PMC7874326.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"472_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238825.PMID:33730058;PMCID:PMC7968651","volume":"16","author":"T Lahmer","year":"2021","unstructured":"Lahmer T, Kriescher S, Herner A, et al. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study. PLoS ONE. 2021;16(3): e0238825. https:\/\/doi.org\/10.1371\/journal.pone.0238825.PMID:33730058;PMCID:PMC7968651.","journal-title":"PLoS ONE"},{"key":"472_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s15010-021-01670-1","volume":"24","author":"JA Al-Tawfiq","year":"2021","unstructured":"Al-Tawfiq JA, Alhumaid S, Alshukairi AN, et al. COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021;24:1\u201321. https:\/\/doi.org\/10.1007\/s15010-021-01670-1 (Epub ahead of print. PMID: 34302291; PMCID: PMC8302461).","journal-title":"Infection"},{"issue":"4","key":"472_CR67","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","volume":"49","author":"WH Chong","year":"2021","unstructured":"Chong WH, Saha BK, Ananthakrishnan R, et al. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49(4):591\u2013605. https:\/\/doi.org\/10.1007\/s15010-021-01602-z (Epub 2021 Mar 11. PMID: 33709380; PMCID: PMC7951131).","journal-title":"Infection"},{"issue":"1","key":"472_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13054-021-03571-z.PMID:33882991;PMCID:PMC8059113","volume":"25","author":"PH Wicky","year":"2021","unstructured":"Wicky PH, Niedermann MS, Timsit JF. Ventilator-associated pneumonia in the era of COVID-19 pandemic: how common and what is the impact? Crit Care. 2021;25(1):153. https:\/\/doi.org\/10.1186\/s13054-021-03571-z.PMID:33882991;PMCID:PMC8059113.","journal-title":"Crit Care"},{"key":"472_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s15010-021-01624-7","volume":"26","author":"A Oliva","year":"2021","unstructured":"Oliva A, Ceccarelli G, Borrazzo C, et al. Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission. Infection. 2021;26:1\u201311. https:\/\/doi.org\/10.1007\/s15010-021-01624-7 (Epub ahead of print. PMID: 34036458; PMCID: PMC8149291).","journal-title":"Infection"},{"issue":"1","key":"472_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13418","volume":"51","author":"G Ceccarelli","year":"2021","unstructured":"Ceccarelli G, Alessandri F, Oliva A, et al. Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021;51(1): e13418. https:\/\/doi.org\/10.1111\/eci.13418.","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"472_CR71","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00134-020-06219-8","volume":"46","author":"M Bassetti","year":"2020","unstructured":"Bassetti M, Kollef MH, Timsit JF. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Med. 2020;46(11):2071\u20134. https:\/\/doi.org\/10.1007\/s00134-020-06219-8 (Epub 2020 Sep 9. PMID: 32902729; PMCID: PMC7479998).","journal-title":"Intensive Care Med"},{"issue":"5","key":"472_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251170.PMID:33956882;PMCID:PMC8101968","volume":"16","author":"JS Musuuza","year":"2021","unstructured":"Musuuza JS, Watson L, Parmasad V, et al. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS ONE. 2021;16(5): e0251170. https:\/\/doi.org\/10.1371\/journal.pone.0251170.PMID:33956882;PMCID:PMC8101968.","journal-title":"PLoS ONE"},{"issue":"4","key":"472_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100229","volume":"2","author":"PK Buehler","year":"2021","unstructured":"Buehler PK, Zinkernagel AS, Hofmaenner DA, et al. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med. 2021;2(4): 100229. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100229.","journal-title":"Cell Rep Med"},{"key":"472_CR74","doi-asserted-by":"publisher","unstructured":"Maataoui N, Chemali L, Patrier J et al. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis. 2021:1\u20138. https:\/\/doi.org\/10.1007\/s10096-021-04213-6. (Epub ahead of print. PMID: 33733394; PMCID: PMC7968559)","DOI":"10.1007\/s10096-021-04213-6"},{"key":"472_CR75","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijid.2020.12.087","volume":"104","author":"MAB Lucien","year":"2021","unstructured":"Lucien MAB, Canarie MF, Kilgore PE, et al. Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings. Int J Infect Dis. 2021;104:250\u20134. https:\/\/doi.org\/10.1016\/j.ijid.2020.12.087 (Epub 2021 Jan 9. PMID: 33434666; PMCID: PMC7796801).","journal-title":"Int J Infect Dis"},{"issue":"3","key":"472_CR76","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11739-020-02537-3","volume":"16","author":"O Para","year":"2021","unstructured":"Para O, Caruso L, Ronchetti M, et al. Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship. Intern Emerg Med. 2021;16(3):789\u201391. https:\/\/doi.org\/10.1007\/s11739-020-02537-3 (Epub 2020 Nov 22. PMID: 33222117; PMCID: PMC7680555).","journal-title":"Intern Emerg Med"},{"issue":"8","key":"472_CR77","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-020-0395-y.PMID:32488173;PMCID:PMC7264971","volume":"18","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Ming D, Ahmad R, et al. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18(8):409\u201310. https:\/\/doi.org\/10.1038\/s41579-020-0395-y.PMID:32488173;PMCID:PMC7264971.","journal-title":"Nat Rev Microbiol"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-021-00472-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-021-00472-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-021-00472-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T11:06:01Z","timestamp":1632567961000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-021-00472-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,25]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1186\/s12941-021-00472-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-79487\/v1","asserted-by":"object"}]},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,25]]},"assertion":[{"value":"19 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prior to study initiation, permission for the retrospective review was requested from the Main Line Health System Institutional Review Board; this was granted on May 6, 2020 (MLHS IRB F\/N-E20-3943B).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HHL is on the speakers' bureau of DaiichiSankyo Co.; DY, LSP, and LK have no conflicting interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}